An open letter to Congress was signed by four U.S. dietary supplement trade associations calling for more clarification for CBD product marketing and sales.
The four groups involved were:
• The American Herbal Products Association (AHPA)
• The Consumer Healthcare Products Association (CHPA)
• The Council for Responsible Nutrition (CRN)
• The United Natural Products Alliance (UNPA)
The plea was for Congress to “to pass legislation to clarify that CBD derived from the hemp plant is a lawful dietary ingredient if the dietary supplement containing the CBD meets established product safety and quality criteria.”
The letter stated that, “While FDA has been working to craft its policy on hemp-derived products…it could take three to five years for even an expedited rule-making process,” according to the industry letter, and “Given the rapidly growing marketplace of products…it is crucial that Congress take quick action to clarify the legal status of hemp-derived CBD dietary supplements…[and]…essential for FDA to have the resources it needs to protect the public from unsafe CBD products.”
They furthered their plea, asking Congress to give the FDA the authority and the resources to quickly set up a clear regulatory framework for the marketplace. The goal is to protect consumers from a rapidly growing and completely unregulated market.
Worries about product safety, quality, and potency are already rampant in the industry. The letter addressed these concerns saying, “Importantly, these products would also be required to fully comply with all other provisions of the FDCA and FDA’s implementing regulations applicable to dietary supplements, including those requiring accurate product labeling and good manufacturing practices as well as the prohibition against making any drug claims.”
The hope is that the industry will quickly be brought up to speed after it was initiated with the reclassifying of hemp last year.